Author:
Mitchell Jolyon P.,Carter I.,Christopher J. D.,Copley M.,Doub W. H.,Goodey A.,Gruenloh C. J.,Larson B. B.,Lyapustina S.,Patel R. B.,Stein S. W.,Suman J. D.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference77 articles.
1. VanOort M. In vitro testing of dry powder inhalers. Aerosol Sci Technol. 1995;22(4):364–73.
2. Mitchell JP, Stein SW, Doub W, Goodey AP, Christopher JD, Patel RB, et al. Determination of passive dry powder inhaler aerodynamic particle size distribution by multi-stage cascade impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) recommendations to support both product quality control and clinical programs. AAPS PharmSciTech. 2019;20 article 206.
3. United States Pharmacopeial Convention. United States Pharmacopeia. Chapter <601>: Inhalation and nasal drug products: aerosols, sprays, and powders – performance quality tests. Rockwell, MD, USA. https://uspnf.com/uspnf/ (visited April 18, 2022).
4. European Directorate for the Quality of Medicines and Healthcare (EDQM). Strasbourg, France. Monograph 2.9.18: preparations for inhalation: aerodynamic assessment of fine particles. https://edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition (visited April 18, 2022).
5. Mitchell JP, Nagel MW. Cascade impactors for the size characterization of aerosols from medical inhalers: their use and limitations. J Aerosol Med. 2003;16(4):341–77.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献